22 results
CORRESP
ALGS
Aligos Therapeutics Inc
22 Dec 22
Correspondence with SEC
12:00am
as Merck was not deemed to be a customer and the provision of research and development (“R&D”) services for others is not part of the Company’s
424B4
eiidf
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
qpfe85nc48jjkprku9l
4 Jun 21
Draft registration statement
12:00am
10-K
00rg ihtj09a6
23 Mar 21
Annual report
4:26pm
10-Q
dc4spe1fousarmtt
25 Nov 20
Quarterly report
5:21pm
424B4
ys1k8
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
esljqzt6
25 Sep 20
IPO registration
5:27pm